Welcome to Marlinspike Hall, ancestral home of the Haddock Clan, the creation of Belgian cartoonist Hergé.
Some Manor-keeping notes:
Navigation is on the right, with an explanation of the blog's fictional basis. HINT: Please read the column labelled "ABOUT THIS BLOG." Enjoy the most recent posts or browse posts by posting date in the Archives. Search the blog for scintillating, obscure topics.
Enjoy your stay! There are some fuzzy slippers over there somewhere, too.
Friday, May 17, 2013
Free Article from "The Journal of Pain Research": Palmitoylethanolamide and Topical Ketamine Cream
Dearest Readers, you know how the words "free" and "CRPS research" are as enticing to me as cataria nepeta to the felines! Nonetheless, the usual caveats are in force. This is not a research study but a case report. Still, as I recently reminded everyone, the entire impetus behind studying ketamine in relationship to CRPS came about as a result of observations made in a single case study, so I withhold judgment. This is something that I suppose could be tried with the assistance of a willing and experienced neurologist or pain management specialist and a compounding pharmacist. Those of us who cannot tolerate creams due to severe allodynia look forward to hearing from those of you still able to slather the stuff on! Treatment of chronic regional pain syndrome type 1 with palmitoylethanolamide and topical ketamine cream: modulation of nonneuronal cells.
Jan M Keppel Hesselink1 and David J Kopsky2
1Institute for Neuropathic Pain, Bosch en Duin, The Netherlands;
2Institute for Neuropathic Pain, Amsterdam, The Netherlands
Correspondence: Jan M Keppel Hesselink, Institute for Neuropathic Pain, Spoorlaan 2a, 3735 Bosch en Duin, The Netherlands, Tel +31 30 6910932, Email firstname.lastname@example.org
Chronic regional pain syndrome (CRPS) can be intractable to treat and patients sometimes suffer for many years. Therefore, new treatment strategies are needed to alleviate symptoms in CRPS patients. This case report describes a patient suffering from intractable CRPS type 1 for 13 years. Due to her swollen painful feet and left knee she is wheelchair-bound. The combination of palmitoylethanolamide and ketamine 10% cream reduced her pain by more than 50% after 1 month of treatment, and a marked reduction in swelling and skin discoloration was noticed. Furthermore, she could walk independently again and she experienced no side effects. Thus, palmitoylethanolamide and topical ketamine could be a combination therapy option for treating CRPS patients.